References
- Brown MS , GoldsteinJL. Familial hypercholesterolemia: genetic, biochemical and pathophysiologic considerations. Adv. Intern. Med.20, 273–296 (1975).
- de Bold AJ . Thirty years of research on atrial natriuretic factor: historical background and emerging concepts. Can. J. Physiol. Pharmacol.89, 527–531 (2011).
- Burnett JCJr, KaoPC, HuDCet al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231, 1145–1147 (1986).
- Goetze JP . B-type natriuretic peptide: from posttranslational processing to clinical measurement. Clin. Chem.58, 83–91 (2012).
- Piran S , LiuP, MoralesA, HershbergerRE. Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure. J. Am. Coll. Cardiol.60, 283–289 (2012).
- Wang TJ , LarsonMG, LevyDet al. Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation 108, 13–16 (2003).
- Pandey KN . The functional genomics of guanylylcyclase/natriuretic peptide receptor-A: perspectives and paradigms. FEBS J.278, 1792–1807 (2011).
- Dries DL , VictorRG, RameJEet al. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 112, 2403–2410 (2005).
- Meirhaeghe A , SandhuMS, McCarthyMIet al. Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of Type 2 diabetes in human populations. Hum. Mol. Genet. 16, 1343–1350 (2007).
- Pfister R , SharpS, LubenRet al. Mendelian randomization study of B-type natriuretic peptide and Type 2 diabetes: evidence of causal association from population studies. PLoS Med. 8(10), e1001112 (2011).
- Hodgson-Zingman DM , KarstML, ZingmanLVet al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N. Engl. J. Med. 359, 158–165 (2008).
- McKie PM , CataliottiA, HuntleyBK, MartinFL, OlsonTM, BurnettJC Jr. A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions. J. Am. Coll. Cardiol. 54, 1024–1032 (2009).
- Gardner DG , ChenS, GlennDJ, GrigsbyCL. Molecular biology of the natriuretic peptide system: implications for physiology and hypertension. Hypertension49, 419–426 (2007).
- Bergen M , GoetzeJP. On the nature of depression: cardiovascular light for a shady condition. Cardiovasc. Endocrinol.2, 38–39 (2013).
- Charron P , AradM, ArbustiniE et al.; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J.31, 2715–2726 (2010).